Back
Speaker illustration

undefined undefined undefined

Presentations Articles

An unexpected cause of asymmetric left ventricular hypertrophy

Event: ESC Congress 2025

Topic: Clinical

Session: Non-cardiac masses in cardio-oncology

Access
Like
Thumbnail

Unveiling a rare genotype in apparent HCM classic phenotype

Event: ESC Congress 2025

Topic: Clinical

Session: Cardiomyopathies and genetics

Access
Like
Thumbnail

The role of fibrosis and inflammation for response and outcome prediction in candidates to cardiac resynchronization therapy: is response the right answer?

Event: ESC Congress 2024

Topic: Cardiac Resynchronisation Therapy (CRT)

Session: Devices in heart failure: new findings

Access
Like
Thumbnail

Relation of QRS duration to response to cardiac resynchronization therapy in patients with left bundle branch block

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Dynamic variation of renal function and novel or old HF biomarkers (ST2, Galectin 3, NT-proBNP) and response to cardiac resynchronization therapy (CRT)

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Multi-biomarkers laboratory strategy for outcome prediction in patients with severe systolic dysfunction submitted to CRT

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Cardiac resynchronisation therapy

Session: Devices / CRT/ ICD / Surgery

Access
Like
Thumbnail

Additional value of Galectin-3 respect to BNP in acute heart failure patients with preserved ejection fraction

Event: HEART FAILURE 2016

Topic: HFpEF - Heart failure with preserved ejection fraction

Session: HFpEF - Heart failure with preserved ejection fraction

Access
Like
Thumbnail

ESC 365 is supported by

novartis Explore sponsored resources